Back

Bora Pharmaceuticals August revenue jumps 59.22% to second-highest monthly level

Verifying
  • Bora Pharmaceuticals reported August consolidated revenue of NT$2.18 billion.
  • August revenue rose 59.22% year-over-year, reaching the company’s second-highest monthly total.
  • Bora Pharmaceutical Services approved a five-year Zhongli Plant II sale-leaseback.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.